- Home
- RBOT vs IOBT Comparison
RBOT vs IOBT Comparison
Compare RBOT & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- IOBT
- Stock Information
- Founded
- RBOT 2014
- IOBT 2014
- Country
- RBOT United States
- IOBT Denmark
- Employees
- RBOT N/A
- IOBT N/A
- Industry
- RBOT Medical Specialities
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- RBOT Health Care
- IOBT Health Care
- Exchange
- RBOT Nasdaq
- IOBT Nasdaq
- Market Cap
- RBOT 54.2M
- IOBT 57.9M
- IPO Year
- RBOT N/A
- IOBT 2021
- Fundamental
- Price
- RBOT $6.72
- IOBT $1.09
- Analyst Decision
- RBOT Hold
- IOBT Strong Buy
- Analyst Count
- RBOT 2
- IOBT 3
- Target Price
- RBOT $9.25
- IOBT $9.33
- AVG Volume (30 Days)
- RBOT 26.1K
- IOBT 210.8K
- Earning Date
- RBOT 03-17-2025
- IOBT 05-13-2025
- Dividend Yield
- RBOT N/A
- IOBT N/A
- EPS Growth
- RBOT N/A
- IOBT N/A
- EPS
- RBOT N/A
- IOBT N/A
- Revenue
- RBOT N/A
- IOBT N/A
- Revenue This Year
- RBOT N/A
- IOBT $59.29
- Revenue Next Year
- RBOT N/A
- IOBT N/A
- P/E Ratio
- RBOT N/A
- IOBT N/A
- Revenue Growth
- RBOT N/A
- IOBT N/A
- 52 Week Low
- RBOT $4.27
- IOBT $0.66
- 52 Week High
- RBOT $19.00
- IOBT $1.79
- Technical
- Relative Strength Index (RSI)
- RBOT 32.31
- IOBT 59.06
- Support Level
- RBOT $7.02
- IOBT $0.90
- Resistance Level
- RBOT $8.47
- IOBT $1.24
- Average True Range (ATR)
- RBOT 0.77
- IOBT 0.10
- MACD
- RBOT -0.08
- IOBT 0.02
- Stochastic Oscillator
- RBOT 28.11
- IOBT 45.42
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.